Notice - Prescription Drug List (PDL): Hydroquinone
Description
The purpose of this Notice of Amendment is to notify about the addition of hydroquinone or its derivatives to the Prescription Drug List (PDL) for human use when sold in concentrations greater than 2% in topical products.
Resources
| Name |
Format |
Description |
Link |
|
21 |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-concernant-modifications/avis-liste-drogues-ordonnance-2018-08-22.html |
|
21 |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/notice-prescription-drug-list-2018-08-22.html |